Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Change in Accured Expenses (2016 - 2026)

Intellia Therapeutics has reported Change in Accured Expenses over the past 12 years, most recently at -$11.9 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 17.12% to -$11.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.8 million through Mar 2026, down 17.04% year-over-year, with the annual reading at -$5.3 million for FY2025, 49.23% up from the prior year.
  • Change in Accured Expenses was -$11.9 million for Q1 2026 at Intellia Therapeutics, down from $9.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $13.6 million in Q3 2022 and troughed at -$22.4 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $3.0 million (2022), against an average of -$332529.4.
  • Year-over-year, Change in Accured Expenses skyrocketed 220.06% in 2022 and then crashed 367.9% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.1 million in 2022, then surged by 194.01% to $9.0 million in 2023, then crashed by 56.23% to $4.0 million in 2024, then surged by 128.36% to $9.0 million in 2025, then crashed by 232.35% to -$11.9 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Change in Accured Expenses are -$11.9 million (Q1 2026), $9.0 million (Q4 2025), and -$715000.0 (Q3 2025).